Search Results - Expert Opinion Videos

Search results within Expert Opinion Videos for: opioid therapy
PAINWeek faculty member Gary Jay discusses what's going on with opioid prescribing today, and why some doctors may be prescribing opioids when they might do better with another medication. ...
Pharmacotherapy and polypharmacy pose special risks for elderly patients, and the use of interventional strategies is increasingly recognized as important for this population. Dr. Bottros reviews some options to consider. ...
Will recently released prescribing guidelines from the CDC advance the cause of rational opioid therapy? Will they lead to better pain practice and better patient outcomes? Dr. Argoff considers the good, the bad, and the ugly... ...
A clinical pharmacy specialist turns the spotlight on an option for chronic pain management that many clinicians may not have considered. Buprenorphine offers advantages to patients who are indicated for opioid therapy, but are at risk for adverse effects, While reimbursement is an issue, it remains an option for providers ...
One approach to maintaining the balance between risks and benefits of opioid therapy for chronic pain has been the development of abuse deterrent formulations. A pain management PA provides an overview of abuse deterrent technologies, both existing and emerging.While developments are encouraging, they are but one part of the solution. ...
Evidence based biobehavioral therapies, including cognitive behavioral therapy (CBT) and biobehavioral training are indicated for a variety of chronic pain conditions, including fibromyalgia and migraine headache. Dr. Buse, a psychologist, researcher and professor of medicine, outlines what primary care should know about the options, using migraine as a presentation example. ...
Special K is often thought of as a drug of abuse, but it also may be a valid opioid replacement. ...
We begin the week on The Daily Dose with a special report from the online journal STAT that reviews the dimensions of the crisis in opioid prescribing for patients with chronic pain. While not breaking new ground in the discussion, the report offers a... ...
In an environment of escalating scrutiny over controlled medications, frontline practitioners who prescribe them for pain therapy need to take the appropriate steps to demonstrate "prescribing for a legitimate medical purpose while acting in the usual course of professional practice." Jennifer Bolen, JD, longtime PAINWeek faculty member, and founder of ...
A specialist in addiction medicine offers guidance in identifying opioid misuse and the appropriate means of withdrawing patients from long term opioid therapy. The longer term management and rehabilitation of these patients is also considered. ...
Chronic pain patients who fail standard treatments represent a growing problem, and a dilemma for health care providers. A pain specialist and senior PAINWeek faculty member discusses what we know about treatment failure, and outlines some elements... ...
This segment introduces the concept of virtual reality and offers an exploration of its utility in combination with other cognitive behavioral therapies in pain management. ...
The existence of opioid induced hyperalgesia as a side effect of chronic opioid therapy has been debated. A pain specialist offers his perspective on its reality and manifestations, and what the primary care clinician can do in response. ...
Dr. Reid reviews some of the age-related complications of geriatric pain management, and discusses the safety and efficacy of both pharmacologic and alternative treatment modalities. The value of collaborative models of care delivery for this patient... ...
Why is complex regional pain syndrome a frustrating and challenging patient presentation? This segment outlines some of the reasons, and offers some pointers on diagnosis and treatment. ...
In this segment, a former law enforcement professional and credentialed pharmacist considers the world of illicit pharmaceutical trafficking from the juncture of prescribers, investigators, and the legal system. What is happening, and how can the... ...
A number of validated risk assessment tools are available to the prescribing clinician, and their use is increasingly important in the current environment for opioid therapy. A clinical psychologist and Certified Pain Educator summarizes what the... ...
Counterfeit medications are a cause of decreased wellness, increased morbidity, and even death. An anesthesiologist and interventional pain physician reviews the origin of counterfeit medications, describes some anti-counterfeiting technologies and... ...
Doctors Gourlay and Heit, specialists in the arena of pain and addition, explore some of the more common issues confronting the primary care clinician in the management of long-term opioid prescribing. The focus is on the challenges of the inherited... ...
Doctors Gourlay and Heit, specialists in the arena of pain and addition, explore some of the more common issues confronting the primary care clinician in the management of long-term opioid prescribing. The focus is on the challenges of the inherited... ...
Most workers compensation claims involve pain treatment, and most of that therapy involves pharmaceuticals. Dr. Foster overviews the trends and treatment guidelines that primary care practitioners should be aware of, to achieve the best outcomes for... ...
Beyond its role in treating opioid dependence, methadone has unique benefits that make it a viable option for chronic pain management. But with these come multiple pitfalls, for which the risks of methadone therapy may outweigh its benefits for some... ...
High-quality research on the safety and efficacy of medical cannabinoids as pain therapy has long been impeded by an adverse regulatory environment. Even as the prominence of medical marijuana continues to grow--in part due to the public health... ...
In response to the escalating crisis of opioid abuse and overdose fatalities, states are adopting dosage thresholds as part of their prescribing guidelines. A clinical pharmacist and public policy professor summarize the public health landscape that... ...
Prescription Drug Monitoring Programs (PDMPs) are widely available, but not yet uniformly used. A clinical pharmacist and associate professor evaluates the current landscape, and what can be improved to enhance their utility in curbing substance... ...
Stem cell therapy is among the newest innovations in the management of chronic pain and degenerative disease, and offers the most promising outlook in terms of success and prognosis. The technique of stem cell extraction is easy and can be done... ...
Dr. McPherson comments on recent consensus guidelines for methadone prescribing, with background on the properties of this analgesic that render it both an attractive and challenging opioid for pain clinicians. Special considerations for patients... ...
Clinicians involved in pain management face a practice environment that is in constant flux. In this segment, an attorney with deep experience in the medico-legal issues confronting pain practitioners outlines steps that they can take to stay current... ...
Although prescription medications are of great benefit to many patients with chronic non-cancer pain, there are significant complications for patients who are either addicted or in recovery. Dr. Durham, a clinical pharmacist, professor of pharmacy,... ...
Must opioid therapy work for everyone to be a valid part of the treatment armamentarium? Dr. Passik considers some of the consequences of "absolutist thinking" that are leading members of the pain community to unnecessarily harsh self-judgements.... ...
A specialist in pain and substance abuse discusses findings from the research on vulnerable populations in the pain community. Patients with pain and concurrent substance use disorders are particularly at risk for depression and suicidal ideation. To... ...
Effective use of naloxone for opioid overdose requires, first, the ability to recognize the symptoms and signs of opioid induced respiratory depression. All healthcare providers, responders, and patients need education in identifying overdose... ...
A clinical professor of pharmacy offers some insights for primary care on best practice in opioid prescribing. Dr Atayee discusses the importance of risk assessment, competence in dosing and titration, and alternate routes of administration,... ...
The role of diet in provoking inflammation and subsequent pain is substantially underappreciated. Dr. Blatman offers pointers to frontline clinicians on what to look for and how to educate patients on the importance of nutrition and dietary selection... ...
A panel of legal and compliance experts discuss some of the issues confronting prescribers of controlled substances in the management of patients who may be abusing and/or diverting their medications. How should clinicians negotiate the terrain... ...
Dr. Atayee overviews some recently approved medications for treatment of opioid-induced constipation, nausea from chemotherapy, and insomnia. Clinical evidence is scarce, but all bear further investigation. ...
A specialist in orthopedic regenerative medicine overviews a therapeutic option for musculoskeletal pain that carries a low risk profile while delivering high success rates. In use for many years, newer advanced forms of prolotherapy are now part of... ...
Dr. Mackey summarizes his PAINWeek presentation on the mechanisms and impact of neuropathic pain, with guidance on clinical assessment and approaches to treatment with emphasis on pharmacological options. ...
By advancing from a problem/solution perspective to a holistic life coaching approach in the management of chronic pain, both clinician and patient can achieve better, more satisfying, longer lasting outcomes. ...
Dr. Schatman critiques the present state of affairs in medical marijuana and illuminates a more promising path for exploration in pain therapy. ...
A professor of occupational therapy discusses VTE and the various reasons why the clinician may overlook the diagnosis when patients present with the classic symptoms of pain. ...
Dr. Robeck describes her clinical experience with group interaction in the provision of pain care and addiction management in the VA setting. ...
A nurse practitioner and Certified Pain Educator discusses some of the changes in the healthcare landscape and complexities of medical practice that confront nurse practitioners as part of the pain management team. ...
An epidemiologist looks at opioid therapy from the perspective of dose vs risk relationships, and comments on how communities can better harness local initiative and interest to combat overdose events. ...
Drs. Carter and Schatman consider the consequences that would accrue from the removal of opioids from the therapeutic options for chronic pain. The segment also discusses the characteristics of a "better" opioid, and the research understanding... ...
Drs. Carter and Schatman consider the consequences that would accrue from the removal of opioids from the therapeutic options for chronic pain. The segment also discusses the characteristics of a "better" opioid, and the research understanding... ...
Dr. Argoff comments on the appropriate role of opioid analgesics as part of therapy for chronic noncancer pain, with observations on protecting legitimate access while preventing abuse. ...
What would the world be like without opioids? Dr. Clark hypothesizes on the implications for patients with pain, and on what the characteristics of a "better" opioid might include. ...
In this 2-part segment, Dr. Passik discusses some of the lessons learned during and following the Decade of Pain Control and Research, and implications for the appropriate engagement of opioid therapy in chronic noncancer pain management. Click... ...
In this 2-part segment, Dr. Passik discusses some of the lessons learned during and following the Decade of Pain Control and Research, and implications for the appropriate engagement of opioid therapy in chronic noncancer pain management. Click... ...
Medical cannabinoids are legal in several states, yet there is prescriber resistance to their use. This segment examines some reasons, and discusses the MOA and appropriate patient scenarios for this therapy. Recorded at PAINWeek 2013. ...
Proper documentation is both an ethical and legal duty of healthcare providers, particularly with respect to opioid therapy. Attorney Bolen discusses critical documentation skills, and outlines common mistakes that clinicians may make in maintaining... ...
A discussion of the evolving medical/administrative/legal landscape that confronts prescribers of opioid medications. Attorney Furman offers additional advice on how clinicians can protect their practices. ...
Dr. Argoff comments on the appropriate role of opioid analgesics as part of therapy for chronic noncancer pain, with observations on protecting legitimate access while preventing abuse. ...
A pharmacist perspective on the pros and cons of opioid treatment agreements ...
An occupational therapist and attorney explains this experiential tool for pain management and how it integrates into a clinician's therapeutic plan. ...
Observations on the effectiveness of music as an element of pain therapy. ...
Pelvic pain affects one-quarter of reproductive age women. Dr. Fitzgerald discusses the impact of pregnancy on pelvic pain, and the role of rehabilitation strategies in treatment. ...
An examination of intrathecal drug therapy- the benefits, and clinical considerations of patient selection and managing treatment expectations. ...
A summary of acupuncture and auricular therapies as alternative medicine techniques, and the role of stress and anxiety in pain progression. ...
Dr. McPherson discusses what the primary care clinician should know about initiating methadone therapy, including an outline of some of the precautions that should be considered with this opioid. ...
Dr. McPherson is an acclaimed professor of pharmacy, primary care practitioner and consultant in hospice and palliative care. This segment explores topical and transdermal pain relievers. ...
Chronic pain can be significantly influenced by psychological factors, and proper recognition and treatment can contribute to clinical success. ...
Dr. McPherson is an acclaimed professor of pharmacy, primary care practitioner and consultant in hospice and palliative care. This segment examines some adverse events that are associated with opioid analgesics. ...
Dr. Walker is an assistant professor of pharmacy practice, and a practitioner in palliative care. Here, she discusses the issue of drug interactions in the palliative care setting. ...
Dr. McPherson is an acclaimed professor of pharmacy, primary care practitioner and consultant in hospice and palliative care. In this segment are her observations on patient prescriber agreements for opioids. ...
Dr. McPherson has published extensively on the topic of opioid conversion calculations. In this segment, she speaks to why this is an important skill set for prescribing clinicians, and summarizes the key steps in the conversion calculation process. ...
Awareness and engagement of instructional design methodologies can be of significant benefit to clinicians engaged in pain management. Pain education is a critical component of pain therapy, and Dr. McPherson discusses how these principles can... ...
An examination of some of the gender based differences in the experience of pain, and in response to treatment modalities. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
An in-depth, 4- part examination of opioid risk assessment in the primary care setting; the need, the tools; the clinician responsibilities. ...
A 2- part examination of some of the chronic pain syndromes that are common in older adults, and the special considerations relating to pharmacology that arise from the physiology of older patients. ...
A 2- part examination of some of the chronic pain syndromes that are common in older adults, and the special considerations relating to pharmacology that arise from the physiology of older patients. ...
Dr. Passik comments on the debate over opioids as appropriate for chronic non-cancer pain, identifying some shortcomings in the arguments from both sides. ...
Dr. Jay discusses some of the issues confronting patients and clinicians in the current environment of cancer pain therapy. ...